These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 5452656
1. [Is it possible to envisage the treatment of various potentially dangerous states with prolonged-action chemotherapy?]. Boissenin JM, Staël P, Poiré R. Ann Med Psychol (Paris); 1970 May; 128(5):776-81. PubMed ID: 5452656 [No Abstract] [Full Text] [Related]
2. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice]. Richou H. Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894 [No Abstract] [Full Text] [Related]
3. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients]. La Mura G, Specchio LM, Corfiati L, Porro V, Bertolino A. Acta Neurol (Napoli); 1974 Jul; 29(4):446-59. PubMed ID: 4615572 [No Abstract] [Full Text] [Related]
5. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics]. Pellet J, Guyotat J, Marie-Cardine M, Dubor P, Favre-Tissot M, Caron F, Cottraux J. J Med Lyon; 1972 Apr 20; 53(227):591-8. PubMed ID: 4404295 [No Abstract] [Full Text] [Related]
6. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)]. Haumonté MT, Hoerdt HP. Ann Med Psychol (Paris); 1972 Feb 20; 1(2):277-83. PubMed ID: 5051257 [No Abstract] [Full Text] [Related]
7. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)]. Polácek J. Cesk Psychiatr; 1982 Feb 20; 78(1):49-55. PubMed ID: 7060182 [No Abstract] [Full Text] [Related]
8. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate]. Auch W. Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981 [No Abstract] [Full Text] [Related]
9. [Clinical experiences with a delayed-action preparation of fluphenazine]. Schwingenheuer J. Arzneimittelforschung; 1972 Nov 10; 22(11):1918-21. PubMed ID: 4633589 [No Abstract] [Full Text] [Related]
10. [Fluphenazine oenanthate in post-hospital treatment]. Lambert PA, Marcou G. Encephale; 1970 Nov 10; ():Suppl:26-32. PubMed ID: 4318811 [No Abstract] [Full Text] [Related]
11. Depot neuroleptics in the treatment of acute psychoses. Guarneri M, Placidi GF, Cassano GB. Encephale; 1979 Nov 10; 5(2):189-93. PubMed ID: 477594 [Abstract] [Full Text] [Related]
12. Fluphenazine enanthate: a report of a clinical trial in psychotic patients. Karkalas Y. Curr Ther Res Clin Exp; 1968 Apr 10; 10(4):196-200. PubMed ID: 4967873 [No Abstract] [Full Text] [Related]
13. [Personal experience with prolonged-action fluphenazine]. Król K, Krystof J. Psychiatr Pol; 1974 Apr 10; 8(2):149-55. PubMed ID: 4830322 [No Abstract] [Full Text] [Related]
14. Fluphenazine enanthate for the difficult psychotic patient. Stewart AR, Lavallee B. Dis Nerv Syst; 1969 Feb 10; 30(2):98-102. PubMed ID: 5774574 [No Abstract] [Full Text] [Related]
15. [Advantages and indications of Moditen-Retard]. Vallade L. Encephale; 1970 Feb 10; ():Suppl:10-3. PubMed ID: 5458707 [No Abstract] [Full Text] [Related]
16. [Direct treatment of psychotic symptoms with an incisive neuroleptic (Dapotum Acutum)]. Bermejo E. Rev Med Suisse Romande; 1976 Dec 10; 96(12):951-3. PubMed ID: 1006000 [No Abstract] [Full Text] [Related]
18. Implications of sustained release phenothiazines: a study of fluphenazine decanoate. Martin IC, Townend RA. Br J Psychiatry; 1974 Feb 10; 124(579):173-6. PubMed ID: 4596672 [No Abstract] [Full Text] [Related]